Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

1,536 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Optimism for a global plastics treaty.
Fletcher S, Evans T. Fletcher S, et al. Science. 2025 Jan 10;387(6730):119. doi: 10.1126/science.adv2404. Epub 2025 Jan 9. Science. 2025. PMID: 39787233
Sexual identity, sexual behavior, and drug use behaviors among people who use drugs in the rural U.S.
Jenkins WD, Beach LB, Schneider J, Friedman SR, Pho MT, Walters S, Ezell J, Young AM, Hennessy C, Miller W, Go VF, Sun C, Seal DW, Westergaard RP, Crane HM, Fredericksen RJ, Ruderman SA, Fletcher S, Ma J, Delaney JA, Plaisance K, Feinberg J, Smith GS, Korthuis PT, Stopka TJ, Friedmann PD, Zule W, Winer M. Jenkins WD, et al. Among authors: fletcher s. J Subst Use Addict Treat. 2025 Jan 26:209629. doi: 10.1016/j.josat.2025.209629. Online ahead of print. J Subst Use Addict Treat. 2025. PMID: 39875013
Metformin intake and risk of metabolic acidosis after radical cystectomy with urinary diversion: A comparative study using data from the TriNetX research network.
Pallauf M, Brönimann S, Rezaee ME, Kohn TP, Fletcher SA, McNamara M, Enikeev D, Shariat SF, Hoffman-Censits J, Smith AK, Singla N. Pallauf M, et al. Among authors: fletcher sa. Urol Oncol. 2025 Jan 22:S1078-1439(24)01055-X. doi: 10.1016/j.urolonc.2024.12.275. Online ahead of print. Urol Oncol. 2025. PMID: 39848843
Long term health outcomes in people with diabetes 12 months after hospitalisation with COVID-19 in the UK: a prospective cohort study.
Gharibzadeh S, Routen A, Razieh C, Zaccardi F, Lawson C, Gillies C, Heller S, Davies M, Atkins H, Bain SC, Lone NL, Poinasamy K, Peto T, Robertson E, Young B, Johnston D, Quint J, Valabhji J, Ismail K, Marks M, Horsley A, Docherty A, Harrison E, Chalmers J, Ho LP, Raman B, Brightling C, Elneima O, Evans R, Greening N, Harris VC, Houchen-Wolloff L, Sereno M, Shikotra A, Singapuri A, Wain L, Langenberg C, Dennis J, Petrie J, Sattar N, Leavy O, Richardson M, Saunders RM, McArdle A, McASuley H, Yates T, Khunti K; PHOSP-COVID Study Collaborative Group. Gharibzadeh S, et al. EClinicalMedicine. 2024 Dec 27;79:103005. doi: 10.1016/j.eclinm.2024.103005. eCollection 2025 Jan. EClinicalMedicine. 2024. PMID: 39834716 Free PMC article.
Human ACE2 transgenic pigs are susceptible to SARS-CoV-2 and develop COVID-19-like disease.
Chau LF, Lillico S, Opriessnig T, Blake R, Tardy L, Lee CH, Maxwell S, Warren C, Thornton E, Mclaughlin CL, McLachlan G, Tait-Burkard C, Fletcher S, Anderson S, Brown S, Gibbard L, Tzelos T, MacMillan-Christensen D, Baillie JK, Dorward DA, Griffiths DJ, Grey F. Chau LF, et al. Among authors: fletcher s. Nat Commun. 2025 Jan 17;16(1):766. doi: 10.1038/s41467-024-54615-1. Nat Commun. 2025. PMID: 39824810 Free PMC article.
The polypharmacy combination of the BCL-2 inhibitor venetoclax (VEN) and the FLT3 inhibitor gilteritinib (GIL) is more active in acute myeloid leukemia cells than novel polypharmacologic BCL-2/FLT3 VEN-GIL hybrid single-molecule inhibitors.
Goodis CC, Eberly C, Chan AM, Kim M, Lowe BD, Civin CI, Fletcher S. Goodis CC, et al. Among authors: fletcher s. Eur J Med Chem. 2024 Dec 22;285:117190. doi: 10.1016/j.ejmech.2024.117190. Online ahead of print. Eur J Med Chem. 2024. PMID: 39813774
1,536 results